article thumbnail

The Importance of Having a Big Data Strategy for Pharmaceutical Organizations

Infosys Consulting

Data silos and inefficiencies: Without a data strategy, organizations frequently struggle to harmonize and integrate data from different sources, creating data silos that impede cooperation and thorough insights.

article thumbnail

Navigating Change: How Regional Payers Stay Ahead

3Pillar Global

Sources: Mercer, WTW, KFF, AON, Minneapolis Fed On top of that, the business environment has shifted. Source: Mercer – [link] They’ve already largely shifted to self-funded plans, bearing risk to lower total spend. Source: McKinsey – [link] Regional payers achieved success with fully-insured products.

Insurance 104
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Delivering responsible AI in the healthcare and life sciences industry

IBM Services

There is a high likelihood that historically underserved communities may use a generative transformer, especially one that is embedded unknowingly into a search engine, to ask for medical advice. Created by a respected Tennessee pharmaceutical firm, Elixir Sulfanilamide was a liquid medication touted to dramatically cure strep throat.

article thumbnail

Optimizing clinical trial site performance: A focus on three AI capabilities

IBM Business Partners

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.

article thumbnail

The GCC Juggernaut: Unleashing the India Capability Stack for Global Impact

Zinnov

With several companies already having strong product and engineering leaders in India, we will soon see more centers becoming hubs of breakthrough innovations. MOSIP, an open-source initiative by IIIT Bangalore, is allowing countries around the world to implement Aadhar-equivalent systems to provide digital identities to their citizens.

article thumbnail

Everest Group Declares ‘The Age of Decentralized Clinical Trials Has Begun’

Everest Group

Everest Group predicts that the adoption of DCTs by pharmaceutical companies will rapidly accelerate as early adopters praise the approach for putting patient experience at the forefront. to various stakeholders responsible for adoption and continued success of DCTs. Find further details and in-depth content at www.everestgrp.com.

article thumbnail

Addressing Information Overload: Facilitate Easier Information Retrieval With AI-Powered Search

Perficient Digital Transformation

In this blog series, we will highlight five ways pharmaceutical, biotechnology, medical device, contract research organizations (CROs), and academic research organizations (AROs) can leverage an artificial intelligence (AI) insight engine to support use cases ranging from drug discovery to regulatory compliance and commercial sales operations.